Currently, there are 95.07M common shares owned by the public and among those 82.43M shares have been available to trade.
The company’s stock has a 5-day price change of -1.79% and 94.51% over the past three months. UPST shares are trading 202.12% year to date (YTD), with the 12-month market performance up to 21.79% higher. It has a 12-month low price of $20.60 and touched a high of $96.43 over the same period. UPST has an average intraday trading volume of 6.27 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 12.66%, 32.59%, and 28.90% respectively.
Institutional ownership of Upstart Holdings Inc (NASDAQ: UPST) shares accounts for 63.06% of the company’s 95.07M shares outstanding.
It has a market capitalization of $7.13B and a beta (3y monthly) value of 2.37. The earnings-per-share (ttm) stands at -$0.75. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.39% over the week and 5.85% over the month.
Analysts forecast that Upstart Holdings Inc (UPST) will achieve an EPS of 0.25 for the current quarter, 0.42 for the next quarter and 2.34 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0.22 while analysts give the company a high EPS estimate of 0.22. Comparatively, EPS for the current quarter was -0.17 a year ago. Earnings per share for the fiscal year are expected to increase by 841.41%, and 54.48% over the next financial year.
Looking at the support for the UPST, a number of firms have released research notes about the stock. Goldman stated their Sell rating for the stock in a research note on July 14, 2025, with the firm’s price target at $71. Piper Sandler coverage for the Upstart Holdings Inc (UPST) stock in a research note released on June 24, 2025 offered a Overweight rating with a price target of $75. Stephens was of a view on June 12, 2025 that the stock is Equal-Weight, while BofA Securities gave the stock Neutral rating on April 29, 2025, issuing a price target of $53. Morgan Stanley on their part issued Equal-Weight rating on February 14, 2025.
